Skip to main content

223.867.01
Special Topics in Vaccine Science

Location
East Baltimore
Term
2nd Term
Department
International Health
Credit(s)
1
Academic Year
2024 - 2025
Instruction Method
In-person
Class Time(s)
Thursday, 3:30 - 4:50pm
Auditors Allowed
Yes, with instructor consent
Available to Undergraduate
Yes
Grading Restriction
Pass/Fail
Course Instructor(s)
Contact Name
Frequency Schedule
Every Year
Prerequisite
Description
Offers a series of seminars (4 per term) on research and access of vaccine against infectious diseases of global importance including COVID-19, emerging infections, childhood illnesses, and other important vaccine-preventable illnesses. Covers scientific, social, economic, political, and ethical dimensions of vaccine research, development and access. Includes leading vaccine experts at JHU, and from other institutions, organizations, government agencies and industry present seminars. Provides the student with an understanding of the pathways leading to development and utilization of vaccines with public health impact.
Learning Objectives
Upon successfully completing this course, students will be able to:
  1. Explain issues of global access to vaccines, including factors such as disease burden, population inequities, demand and access issues with respect to vaccines
  2. Describe the key barriers along the process of research, development, testing, evaluation, acquisition, and distribution of vaccines
  3. Cite specific examples of how social, political and economic factors interact with scientific issues to affect governmental and industry prioritization about vaccine development and distribution.
  4. Describe how stakeholder motives (investor, corporate, public health agency, individual) can influence the fate of a vaccine research and development project
Methods of Assessment
This course is evaluated as follows:
  • 100% Participation
Special Comments

This is the onsite section of a course that is also held virtually/online. You must commit to the modality in which you register.